Legis Daily

End Taxpayer Subsidies for Drug Ads Act

USA117th CongressS-141| Senate 
| Updated: 1/28/2021
Jeanne Shaheen

Jeanne Shaheen

Democratic Senator

New Hampshire

Cosponsors (22)
Mazie K. Hirono (Democratic)Margaret Wood Hassan (Democratic)Dianne Feinstein (Democratic)Patrick J. Leahy (Democratic)Richard J. Durbin (Democratic)Jack Reed (Democratic)Kirsten E. Gillibrand (Democratic)Elizabeth Warren (Democratic)Angus S. King (Independent)Amy Klobuchar (Democratic)Tim Kaine (Democratic)Sheldon Whitehouse (Democratic)Joe Manchin (Independent)Chris Van Hollen (Democratic)Christopher Murphy (Democratic)Michael F. Bennet (Democratic)Tina Smith (Democratic)Sherrod Brown (Democratic)Bernard Sanders (Independent)Brian Schatz (Democratic)Tammy Baldwin (Democratic)Richard Blumenthal (Democratic)

Finance Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
End Taxpayer Subsidies for Drug Ads Act This bill prohibits a tax deduction for expenses relating to direct-to-consumer advertising of prescription drugs. Direct-to-consumer advertising is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is in regard to the drug product and primarily targeted to the general public.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

S 116-73
End Taxpayer Subsidies for Drug Ads Act
Jan 28, 2021
Introduced in Senate
Jan 28, 2021
Read twice and referred to the Committee on Finance.
  • Bill from Previous Congress

    S 116-73
    End Taxpayer Subsidies for Drug Ads Act


  • January 28, 2021
    Introduced in Senate


  • January 28, 2021
    Read twice and referred to the Committee on Finance.

Taxation

Related Bills

  • S 117-1898: Affordable Medications Act
  • HR 117-6392: No Tax Breaks for Drug Ads Act
Business expensesIncome tax deductionsMarketing and advertisingPrescription drugs

End Taxpayer Subsidies for Drug Ads Act

USA117th CongressS-141| Senate 
| Updated: 1/28/2021
End Taxpayer Subsidies for Drug Ads Act This bill prohibits a tax deduction for expenses relating to direct-to-consumer advertising of prescription drugs. Direct-to-consumer advertising is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is in regard to the drug product and primarily targeted to the general public.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

S 116-73
End Taxpayer Subsidies for Drug Ads Act
Jan 28, 2021
Introduced in Senate
Jan 28, 2021
Read twice and referred to the Committee on Finance.
  • Bill from Previous Congress

    S 116-73
    End Taxpayer Subsidies for Drug Ads Act


  • January 28, 2021
    Introduced in Senate


  • January 28, 2021
    Read twice and referred to the Committee on Finance.
Jeanne Shaheen

Jeanne Shaheen

Democratic Senator

New Hampshire

Cosponsors (22)
Mazie K. Hirono (Democratic)Margaret Wood Hassan (Democratic)Dianne Feinstein (Democratic)Patrick J. Leahy (Democratic)Richard J. Durbin (Democratic)Jack Reed (Democratic)Kirsten E. Gillibrand (Democratic)Elizabeth Warren (Democratic)Angus S. King (Independent)Amy Klobuchar (Democratic)Tim Kaine (Democratic)Sheldon Whitehouse (Democratic)Joe Manchin (Independent)Chris Van Hollen (Democratic)Christopher Murphy (Democratic)Michael F. Bennet (Democratic)Tina Smith (Democratic)Sherrod Brown (Democratic)Bernard Sanders (Independent)Brian Schatz (Democratic)Tammy Baldwin (Democratic)Richard Blumenthal (Democratic)

Finance Committee

Taxation

Related Bills

  • S 117-1898: Affordable Medications Act
  • HR 117-6392: No Tax Breaks for Drug Ads Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Business expensesIncome tax deductionsMarketing and advertisingPrescription drugs